scholarly journals VP07.04: Specifics of endometrial peristalsis in t‐shaped uterine anomaly

2021 ◽  
Vol 58 (S1) ◽  
pp. 125-125
Author(s):  
K. Tokhunts ◽  
M. Adamyan ◽  
A. Khudaverdyan
Keyword(s):  
1987 ◽  
Vol 15 (3) ◽  
pp. 165-170 ◽  
Author(s):  
David R. Pennes ◽  
Richard A. Bowerman ◽  
Terry M. Silver ◽  
Steven J. Smith

2017 ◽  
Vol 3 (1) ◽  
pp. 31-33
Author(s):  
Nagendra Prasad ◽  
James Thingujam

ABSTRACT Maternal with congenitial anomalies are known to have higher incidence of infertility, intrauterine growth restriction, fetal malposition, preterm labor, preterm premature rupture of membrane and increased cesaerean section rate. Study Design This is retrospective study, the pregnancies with uterine anomaly confirmed by ultrasound between Jan 2016 to jan 2017 at our hospital was taken and its outcome is observed. Reults The majority of preterm delivery in our study are mainly associated with septate and bicornuate uterus. Cesaerean section comprised of 80% and its major indication is due to fetal malpresentation (breech). Thus Pregnancy outcomes of individual depending on the type of uterine anomalies. How to cite this article Nagarathnamma R, James T, Prasad N. Pregnancy Outcome in Uterine Anomalies. J Med Sci 2017;3(1):31-33.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
H Yoshihara ◽  
M Sugiura-Ogasawara ◽  
T Kitaori ◽  
S Goto

Abstract Study question Can antinuclear antibody (ANA) affect the subsequent live birth rate in patients with recurrent pregnancy loss (RPL) who have no antiphospholipid antibodies (aPLs)? Summary answer ANA did not affect the pregnancy prognosis of RPL women. What is known already The prevalence of ANA is well-known to be higher in RPL patients. Our previous study found no difference in the live birth rates of ANA-positive and -negative patients who had no aPLs. Higher miscarriage rates were also reported in ANA-positive patients compared to ANA-negative patients with RPL. The RPL guidelines of the ESHRE state that “ANA testing can be considered for explanatory purposes.” However, there have been a limited number of studies on this issue and sample sizes have been small, and the impact of ANA on the pregnancy prognosis is unclear. Study design, size, duration An observational cohort study was conducted at Nagoya City University Hospital between 2006 and 2019. The study included 1,108 patients with a history of 2 or more pregnancy losses. Participants/materials, setting, methods 4D-Ultrasound, hysterosalpingography, chromosome analysis for both partners, aPLs and blood tests for ANA and diabetes mellitus were performed before a subsequent pregnancy. ANAs were measured by indirect immunofluorescence. The cutoff dilution used was 1:40. In addition, patients were classified according to the ANA pattern on immunofluorescence staining. Live birth rates were compared between ANA-positive and ANA-negative patients after excluding patients with antiphospholipid syndrome, an abnormal chromosome in either partner and a uterine anomaly. Main results and the role of chance The 994 patients were analyzed after excluding 40 with a uterine anomaly, 43 with a chromosome abnormality in either partner and 32 with APS. The rate of ANA-positive patients was 39.2 % (390/994) when the 1: 40 dilution result was positive. With a 1:160 dilution, the rate of ANA-positive patients was 3.62 % (36/994). The live birth rate was calculated for 798 patients, excluding 196 patients with unexplained RPL who had been treated with any medication. With the use of the 1 40 dilution, the subsequent live birth rates were 71.34 % (219/307) for the ANA-positive group and 70.67 % (347/491) for the ANA-negative group (OR, 95%CI; 0.968, 0.707-1.326). After excluding miscarriages with embryonic aneuploidy, chemical pregnancies and ectopic pregnancies, live birth rates were 92.41 % (219/237) for the ANA-positive group and 92.04 % (347/377) for the ANA-negative group (0.951, 0.517-1.747). Using the 1:160 dilution, the subsequent live birth rates were 84.62 % (22/26) for the ANA-positive group, and 70.47 % (544/772) for the ANA-negative group (0.434, 0.148-1.273). Subgroup analyses were performed for each pattern on immunofluorescence staining, but there was no significant difference in the live birth rate between the two groups. Limitations, reasons for caution The effectiveness of immunotherapies could not be evaluated. However, the results of this study suggest that it is not necessary. Wider implications of the findings The measurement of ANA might not be necessary for the screening of patients with RPL who have no features of collagen disease. Trial registration number not applicable


Author(s):  
Christine U. Lee ◽  
James F. Glockner

30-year-old woman with a possible uterine anomaly on pelvic US Axial (Figure 10.10.1) and coronal oblique (Figure 10.10.2) fat-suppressed FSE T2-weighted images reveal 2 uterine horns with a moderate uterine cleft and a septum extending throughout the endometrial cavity and cervix. A coronal large field-of-view SSFSE image (...


Author(s):  
Christine U. Lee ◽  
James F. Glockner

20-year-old woman with a congenital uterine anomaly Axial (Figure 10.8.1) and coronal (Figure 10.8.2) FSE T2-weighted images reveal 2 separate uterine horns and separate cervices. Note also 2 distinct vaginal canals, both distended with fluid. Uterine didelphys with vaginal septum...


2006 ◽  
Vol 28 (4) ◽  
pp. 488-489
Author(s):  
K. W. Kim ◽  
J. K. Jun ◽  
S. S. Shim ◽  
J. S. Park ◽  
B. H. Yoon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document